✦ LIBER ✦

The treatment of malignant pleural effusions

✍ Scribed by Dr. Charles B. Anderson; Gordon W. Philpott; Thomas B. Ferguson

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 553 KB
Volume: 33
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197404)33:4<916::aid-cncr2820330405>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intrapleural talc for the treatment of m

Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer

✍ Ribas C. Milanez; Francisco S. Vargas; Luiz B. Filomeno; Lisete R. Teixeira; Ang 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 2 views

Background. The management of malignant pleural effusions secondary to breast cancer is a difficult problem. In the 1980s tetracycline was probably the most commonly used sclerosing agent, but parenteral tetracycline is no longer available. Therefore, it is important to evaluate alternative sclerosi

Early experience with videothoracoscopic

Early experience with videothoracoscopic hydrodissection pleurectomy in the treatment of malignant pleural effusion

✍ James C. Harvey; Christopher B. Erdman; Edward J. Beattie 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

## Abstract Parietal pleurectomy is our preferred procedure for management of malignant pleural effusion. However, the morbidity of a major thoracotomy has precluded all but highly selected patients from the conventional (open) procedure. Recently, we have been able to perform parietal pleurectomy

A comparative trial of LC9018 plus doxor

A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer

✍ Tomiya Masuno; Susumu Kishimoto; Takeshi Ogura; Takeshi Honma; Hisanobu Niitani; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The efficacy and safety of intrapleural LC9018 (Yakult Co. Ltd., Tokyo, Japan) with or without doxorubicin (Adriamycin; Adria Laboratories, Columbus, OH) were evaluated in a randomized, controlled trial performed in 95 patients with malignant pleural effusions secondary to lung cancer. Seventy-six p

Management of malignant pleural effusion

✍ David W. Greenwald; Clay Phillips; John M. Bennett 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

## Abstract A pleural effusion is a frequent complication of malignant disease. Essential to the care of oncology patients is a fundamental knowledge of the pathophysiology and treatment of such effusions. This article discusses the current thoughts concerning the occurrence of malignant effusions,

Pleuroperitoneal shunting for malignant

Pleuroperitoneal shunting for malignant pleural effusions

✍ Alex G. Little; Mark K. Ferguson; Harvey M. Golomb; Philip C. Hoffman; Nicholas 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

Cisplatin and cytarabine administered in

Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusions

✍ Markman, Maurie ;Cleary, Stephen ;King, Mark E. ;Howell, Stephen B. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB